Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

PRPH – ProPhase Labs Inc

ProPhase Labs, Inc.
PRPH
$0.2881
Name : ProPhase Labs, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $12,065,340.00
EPSttm : -2.42
finviz dynamic chart for PRPH
ProPhase Labs, Inc.
$0.2881
2.75%
$0.0077

Float Short %

3.21

Margin Of Safety %

Put/Call OI Ratio

0.03

EPS Next Q Diff

EPS Last/This Y

2.05

EPS This/Next Y

0.56

Price

0.29

Target Price

16

Analyst Recom

1

Performance Q

-51.98

Relative Volume

0.05

Beta

-0.31

Ticker: PRPH




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-20PRPH0.38230.040.003075
2025-03-21PRPH0.33210.040.003075
2025-03-24PRPH0.42430.020.242501
2025-03-25PRPH0.47510.020.082510
2025-03-26PRPH0.47830.030.732546
2025-03-27PRPH0.48310.050.032684
2025-03-28PRPH0.42620.050.022733
2025-03-31PRPH0.40910.050.032786
2025-04-01PRPH0.420.04999.992888
2025-04-02PRPH0.38660.040.042888
2025-04-03PRPH0.350.040.042888
2025-04-04PRPH0.2440.040.002913
2025-04-07PRPH0.27890.040.033109
2025-04-08PRPH0.250.030.133638
2025-04-09PRPH0.28570.030.333647
2025-04-10PRPH0.27180.030.003649
2025-04-11PRPH0.30960.037.503647
2025-04-14PRPH0.30560.037.503647
2025-04-15PRPH0.2910.037.503647
2025-04-16PRPH0.28730.030.003637
2025-04-17PRPH0.28690.031.003638
2025-04-18PRPH0.28810.031.003638
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-20PRPH0.3952.9- -1.23
2025-03-21PRPH0.3752.9- -1.23
2025-03-24PRPH0.4352.9- -1.23
2025-03-25PRPH0.4852.9- -1.23
2025-03-26PRPH0.4852.9- -1.23
2025-03-27PRPH0.4752.9- -1.23
2025-03-28PRPH0.4452.9- -1.23
2025-03-31PRPH0.4052.9- -1.23
2025-04-01PRPH0.4052.9- -1.23
2025-04-02PRPH0.3952.9- -1.23
2025-04-03PRPH0.3552.9- -1.23
2025-04-04PRPH0.24-157.1- -0.56
2025-04-07PRPH0.27-157.1- -0.56
2025-04-08PRPH0.25-157.1- -0.56
2025-04-09PRPH0.29-157.1- -0.56
2025-04-10PRPH0.27-157.1- -0.56
2025-04-11PRPH0.31-157.1- -0.56
2025-04-14PRPH0.30-157.1- -0.56
2025-04-15PRPH0.29-157.1- -0.56
2025-04-16PRPH0.28-157.1- -0.56
2025-04-17PRPH0.29-157.1- -0.56
2025-04-18PRPH0.29-157.1- -0.56
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-20PRPH0.0025.856.30
2025-03-21PRPH0.0025.856.30
2025-03-24PRPH0.0034.476.30
2025-03-25PRPH0.0034.476.30
2025-03-26PRPH0.0034.473.01
2025-03-27PRPH0.0034.473.01
2025-03-28PRPH0.0034.473.01
2025-03-31PRPH0.0034.473.01
2025-04-01PRPH0.0034.473.01
2025-04-02PRPH0.0034.473.01
2025-04-03PRPH0.0034.473.01
2025-04-04PRPH0.0034.473.01
2025-04-07PRPH0.0022.410
2025-04-08PRPH0.0022.412.15
2025-04-09PRPH0.0022.412.15
2025-04-10PRPH0.0022.413.21
2025-04-11PRPH0.0022.413.21
2025-04-14PRPH0.0034.123.21
2025-04-15PRPH0.0034.123.21
2025-04-16PRPH0.0034.123.21
2025-04-17PRPH0.0034.123.21
2025-04-18PRPH0.0034.123.21
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.24

Avg. EPS Est. Next Quarter

-0.15

Insider Transactions

Institutional Transactions

34.12

Beta

-0.31

Average Sales Estimate Current Quarter

5

Average Sales Estimate Next Quarter

3

Fair Value

Quality Score

14

Growth Score

33

Sentiment Score

18

Actual DrawDown %

98.2

Max Drawdown 5-Year %

-98.4

Target Price

16

P/E

Forward P/E

PEG

P/S

0.95

P/B

0.14

P/Free Cash Flow

EPS

-1.5

Average EPS Est. Cur. Y​

-0.56

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-217.64

Relative Volume

0.05

Return on Equity vs Sector %

-745.7

Return on Equity vs Industry %

-736.5

EPS 1 7Days Diff

EPS 1 30Days Diff

0.24

EBIT Estimation

ProPhase Labs, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 96
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
stock quote shares PRPH – ProPhase Labs Inc Stock Price stock today
news today PRPH – ProPhase Labs Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PRPH – ProPhase Labs Inc yahoo finance google finance
stock history PRPH – ProPhase Labs Inc invest stock market
stock prices PRPH premarket after hours
ticker PRPH fair value insiders trading